Dear Fellow Investor,
A small, under-the-radar biotech company just raised $500 MILLION to combat Alzheimer's, Parkinson's and other brain disorders.
They accomplished this thanks to a revolutionary new drug delivery technology that solves one of biotech's oldest problems.
You see, getting drugs into the brain is extremely difficult. The blood-brain barrier blocks almost everything.
But this company engineered a way to sneak their treatments across the barrier using a "smuggler."
With an extra $500 million in funding, they can now accelerate development of medicines targeting Alzheimer's, Parkinson's, and more.
Even Big Pharma giant Biogen licensed this biotech's clever delivery system last year.
But you'll want to get in before more partnerships emerge...
Reveal this game-changing biotech's name and ticker HERE >>>
"The Buck Stops Here,"
Dylan Jovine, CEO & Founder
Behind the Markets
没有评论:
发表评论